ImageneBio (IMA) Return on Capital Employed (2021 - 2024)

Historic Return on Capital Employed for ImageneBio (IMA) over the last 4 years, with Q3 2024 value amounting to 0.4%.

  • ImageneBio's Return on Capital Employed fell 100.0% to 0.4% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.4%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.45% for FY2023, which is 700.0% down from last year.
  • As of Q3 2024, ImageneBio's Return on Capital Employed stood at 0.4%, which was down 100.0% from 0.48% recorded in Q2 2024.
  • In the past 5 years, ImageneBio's Return on Capital Employed registered a high of 0.15% during Q4 2021, and its lowest value of 0.48% during Q2 2024.
  • Its 4-year average for Return on Capital Employed is 0.34%, with a median of 0.39% in 2023.
  • In the last 5 years, ImageneBio's Return on Capital Employed crashed by -2900bps in 2022 and then skyrocketed by 500bps in 2023.
  • Over the past 4 years, ImageneBio's Return on Capital Employed (Quarter) stood at 0.15% in 2021, then crashed by -196bps to 0.44% in 2022, then rose by 10bps to 0.4% in 2023, then fell by -1bps to 0.4% in 2024.
  • Its Return on Capital Employed was 0.4% in Q3 2024, compared to 0.48% in Q2 2024 and 0.45% in Q1 2024.